Can a single injection tame high triglycerides?

NCT ID NCT07766759

Not yet recruiting Disease control Sponsor: Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This early-stage trial tests a single injection of an experimental drug called FXR0906 in healthy adults with slightly elevated triglycerides, a type of fat in the blood linked to heart risk. The study aims to see if the drug is safe, how the body processes it, and whether it lowers triglyceride levels. Half of the participants will receive the drug and half a placebo, with neither they nor the researchers knowing who got which.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FXR0906 injection
What this could lead to: If successful, this could lead to a new once-daily injection to help manage high triglycerides, a risk factor for heart disease.
What could go wrong: This is an early Phase 1 trial with only 24 participants, so safety and effectiveness are not yet established. The drug may not lower triglycerides as hoped or may cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULT VOLUNTEERS

Contacts and locations

Show contact details

Locations

Peking University Third Hospital

Beijing, Beijing Municipality, 100000, China

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.